Remove .Net Remove 2016 Remove Report Remove Sales
article thumbnail

The Five Major Tech Trends of 2016

Xconomy

As we draw closer to the end of 2016, it is important that we take a moment to look back and reflect on all of the ways technology has inspired us, and transformed the way we live and do work. Meanwhile, biometrics has stepped out of the realm of sci-fi and into the mainstream, playing an important role in the fight against cybercrime.

article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I widened my net this year. The results were so encouraging, we’re doing it again.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. STAT found the figures in Editas’s quarterly earnings report. Talk about sacrifice.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

The deal also includes a $175 million deferred payment due in 2019 and $850 million in downstream payouts tied to regulatory and sales targets. A Phase 2 trial of the drug, AMX0035, should start in late 2016 or early 2017. Alex Lash contributed to this report. Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 40